Quest Diagnostics Introduces Testing for Oropouche Virus
Diagnostic testing for emerging infectious disease associated with severe neurological affects SECAUCUS, N.J., July 15, 2025 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the Oropouche virus, an emerging disease that is increasingly found in South and Central America and the
Quest Diagnostics Introduces Testing for Oropouche Virus Read Post »
Press







